Evidence map›Paper›PMID 35110096›Full record

ArticleThe Eurasian journal of medicine2021

Turkish Validity and Reliability Study of Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ).

İbrahim Özlü, Atıf Bayramoğlu

Open access · diamondAbstract read
In one paragraph

Article in The Eurasian journal of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

İbrahim ÖzlüDepartment of Emergency, Atatürk University School of Medicine, Erzurum, Turkey.
Atıf BayramoğluDepartment of Emergency Medicine, Atatürk University School of Medicine, Erzurum, Turkey.
Atatürk University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAtrial fibrillation (AF) is the most commonly encountered arhythmia in clinical practice and constitutes one-third of the hospitalizations related to cardiac dysrhythmia. Furthermore, it is the most common reason for hospital admissions involving dysrhythmia complaints and is associated with the decrease in quality of life, functional capacity, cardiac performance, and lifespan. MATERIALS AND

methodsThis methodological study, which aims to assess the validity and reliability of the JAKQ, was conducted with patients (n = 175) who were admitted to the emergency clinic of Atatürk University Research Hospital between December 2016 and June 2018 and who were diagnosed with atrial fibrillation and met the inclusion criteria. The data were collected using a "Personal Information Form" and the "Jessa Atrial Fibrillation Knowledge Questionnaire (JAKQ).

resultsThe exploratory factor analysis carried out to determine the construct validity of the scale showed that it had a three-dimensional structure and that its factor loads were within the appropriate range. The internal consistency analyses of the scale revealed that the Cronbach's alpha coefficient was 0.84 and that the item-total score correlations were at an adequate level. The correlation value of the test-retest conducted to test the time invariance of the scale was found to be 0.87, and there was a statistically significant relationship between the two applications (P < .001).

conclusionThe study results showed that the structure of the Turkish version of the Jessa Atrial Fibrillation Questionnaire was similar to the structure of the original scale, that its validity and reliability were considerably high and that it could be used in Turkey.

Identifiers

PMID35110096
PMCPMC9879223
OpenAlexW3214435395

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.